Genetic Characterization of Dilated Cardiomyopathy in Romanian Adult Patients

Oana Raluca Voinescu,Bogdana Ioana Ionescu,Sebastian Militaru,Andreea Sorina Afana,Radu Sascau,Laura Vasiliu,Sebastian Onciul,Mihaela Amelia Dobrescu,Ramona Alina Cozlac,Dragos Cozma,Raluca Rancea,Bogdan Dragulescu,Nicoleta Ioana Andreescu,Maria Puiu,Ruxandra Oana Jurcut,Adela Chirita-Emandi
DOI: https://doi.org/10.3390/ijms25052562
IF: 5.6
2024-02-23
International Journal of Molecular Sciences
Abstract:Dilated cardiomyopathy (DCM) represents a group of disorders affecting the structure and function of the heart muscle, leading to a high risk of heart failure and sudden cardiac death (SCD). DCM frequently involves an underlying genetic etiology. Genetic testing is valuable for risk stratification, treatment decisions, and family screening. Romanian population data on the genetic etiology of DCM are lacking. We aimed to investigate the genetic causes for DCM among Romanian adult patients at tertiary referral centers across the country. Clinical and genetic investigations were performed on adult patients presenting to tertiary hospitals in Romania. The genetic investigations used next-generation sequencing panels of disease-associated DCM genes. A total of 122 patients with DCM underwent genetic testing. The mean age at DCM diagnosis was 41.6 ± 12.4 years. The genetic investigations identified pathogenic or likely pathogenic variants in 50.8% of participants, while 25.4% had variants of unknown significance. Disease-causing variants in 15 genes were identified in people with DCM, with 31 previously unreported variants. Variants in TTN, LMNA, and DSP explained 75% of genetic causes for DCM. In total, 52.4% of patients had a family history of DCM/SCD. Left ventricular ejection fraction of <35% was observed in 41.9% of patients with disease-causing variants and 55% with negative or uncertain findings. Further genotype-phenotype correlations were explored in this study population. The substantial percentage (50.8%) of disease-causing variants identified in patients with DCM acknowledges the importance of genetic investigations. This study highlights the genetic landscape in genes associated with DCM in the Romanian population.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?
### Problems the paper attempts to solve This paper aims to explore the genetic characteristics of dilated cardiomyopathy (DCM) in Romanian adult patients. Specifically, the research objectives include: 1. **Investigate the effectiveness of genetic testing in the diagnosis of DCM**: - Researchers identify pathogenic or likely pathogenic variants causing DCM through genetic testing to evaluate the diagnostic value of genetic testing in Romanian adult patients. 2. **Analyze the differences between patients with significant genetic findings and those without significant findings**: - Compare the clinical characteristics of patients with pathogenic variants and those with no variants or variants of uncertain significance to understand whether diagnostic efficiency can be improved in the case of limited resources by optimizing patient selection. 3. **Explore the genotype - phenotype correlation of DCM in the Romanian population**: - Evaluate the relationship between different gene variants and clinical manifestations to help improve the clinical management of DCM. 4. **Describe the genetic background of DCM in the Romanian population**: - Identify DCM - related genes with a high incidence in the Romanian population, so as to conduct more focused and cost - effective genetic testing in the future. ### Main findings - **Effectiveness of genetic testing**: - Among 122 DCM patients, 50.8% of the patients were detected with pathogenic or likely pathogenic variants, among which 31 variants were newly reported for the first time. - 75% of the genetic causes were explained by variants in three genes: TTN, LMNA and DSP. - **Comparison of clinical characteristics**: - The incidence of atrial fibrillation in patients with pathogenic variants was significantly higher than that in patients with no variants or variants of uncertain significance. - The proportion of women was higher in familial DCM patients, and the age of diagnosis and follow - up was lower. - **Genotype - phenotype correlation**: - Patients carrying LMNA variants were more likely to have cardiac conduction disorders, atrial fibrillation and implanted devices than those carrying TTN variants. - All patients carrying LMNA variants showed fibrosis in cardiac magnetic resonance imaging, while 76.2% of patients carrying TTN variants showed fibrosis. - **Specific cases**: - Two patients carried multiple pathogenic variants, one patient carried both PLN and TTN variants simultaneously, and the other patient carried MYBPC3 and PLN variants. - A female patient carrying a homologous PLN variant presented with severe DCM. Through these studies, the paper emphasizes the importance of genetic testing in the diagnosis of DCM and provides valuable references for future clinical management and genetic testing.